Mebendazole as Adjuvant Treatment for Colon Cancer

Sherief Abd-Elsalam

Status and phase: Enrolling; Phase 3

Conditions: Colorectal Cancer

Treatments: Drug: Folfox with avastin; Drug: Mebendazole

Study type: Interventional

Funder types: Other

Identifiers

NCT03925662

colon cancer

Details and patient eligibility

About

mebendazole treating colon cancer

Full description

mebendazole as adjuvant treatment for colon cancer

Enrollment: 40 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Colorectal cancer stage 4.

Exclusion criteria

• Agranulocytosis
• Pregnancy
• Allergy to mebendazole.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: None (Open label)

---

40 participants in 2 patient groups

Folfox with avastin

Active Comparator group

Description:

Folfox with avastin only

Treatment:

Drug: Folfox with avastin

Mebendazole

Experimental group

Description:

Folfox with avastin with mebendazole

Treatment:

Drug: Mebendazole